Huahai Pharmaceutical board maintains convertible bond conversion price

Zhejiang Huahai Pharmaceutical Co., Ltd. held the sixth extraordinary meeting of its ninth board of directors on November 5, 2025. All nine directors attended the communication-based meeting, meeting quorum requirements. Chaired by Mr. Li Hong, the company's chairman, the meeting procedures adhered to legal requirements.

The board unanimously approved the "Proposal on Not Revising Downward the Conversion Price of 'Huahai Convertible Bonds'," with 9 votes in favor, 0 against, and 0 abstentions.

Further details regarding this decision are scheduled to be published by the company on November 6, 2025, in various financial news outlets and on the Shanghai Stock Exchange website.